X
    X
    X
    X

    Juvenescence Limited

    A Locke Lord team led by Douglas Gray and Baker Coon (both of Providence) represented Juvenescence Limited, a leading drug development company based in the British Virgin Islands and focused on the development of therapies to increase human longevity, in connection with its latest investment in BYOMass Inc., a Massachusetts-based company focused on developing treatments for obesity and cachexia. Juvenescence will support BYOMass with up to $6.5 million in equity financing, in addition to its therapy and drug development capabilities. Additional team members included Lori Basilico (Providence), Richard Glovsky and Ralph Loren (both of Boston).
    Posted on April 1, 2019

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.